John Dobak
2020
In 2020, John Dobak earned a total compensation of $3.5M as Chief Executive Officer at DermTech, a 127% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,200 |
|---|---|
| Option Awards | $1,400,849 |
| Salary | $480,000 |
| Stock Awards | $1,395,675 |
| Other | $557 |
| Total | $3,464,281 |
Dobak received $1.4M in option awards, accounting for 40% of the total pay in 2020.
Dobak also received $187.2K in non-equity incentive plan, $480K in salary, $1.4M in stock awards and $557 in other compensation.
Rankings
In 2020, John Dobak's compensation ranked 3,347th out of 13,090 executives tracked by ExecPay. In other words, Dobak earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,347 out of 13,090 | 74th |
Division Services | 730 out of 2,341 | 69th |
Major group Health Services | 70 out of 252 | 72nd |
Industry group Medical And Dental Laboratories | 18 out of 73 | 75th |
Industry Medical Laboratories | 18 out of 73 | 75th |
Source: SEC filing on April 16, 2021.
Dobak's colleagues
We found four more compensation records of executives who worked with John Dobak at DermTech in 2020.